Key result
Total artificial heart implantation for alternative indications showed a trend toward decreased survival to transplantation compared with biventricular heart failure.
Why the study?
Does survival to transplantation differ between patients receiving a Total Artificial Heart for alternative indications versus biventricular heart failure?
Cohort (n=66)
No
Does survival to transplantation differ between patients receiving a Total Artificial Heart for alternative indications versus biventricular heart failure?
Total artificial heart implantation is an effective bridge to transplantation, achieving an 86% overall survival rate with comparable outcomes between standard biventricular heart failure and alternative indications.
Answers are grounded in this paper and cite their sources.
Does not support restricting total artificial heart use by indication; leaves open outcome equivalence in larger cohorts.
The total artificial heart (TAH) is effective for bridging patients with biventricular heart failure (BiVHF) to transplantation. It consists of two pneumatic pumps with four mechanical valves that replace nearly the entire myocardium, thus also making it effective therapy for heart failure from alternative (ALT) anatomical and pathophysiological causes that preclude left ventricular assist device (LVAD). This report reviews the clinical indications and outcomes for TAH implantation at our institution from 2006 to 2012. We sought to characterize and compare survival to transplant for patients with BiVHF to those with ALT indications. The overall survival to transplant for all patients was 86% (57/66). There was a trend towards decreased survival to transplantation in the ALT group compared with the BiVHF group (77% vs. 93%, HR 0.42 [95% confidence interval 0.1, 1.7], log-rank test: p = 0.2). This was likely driven by certain high risk subgroups of allograft failure, LVAD failure, and acute postinfarct shock.
No takes yet. Share an insight, caveat, or question.
Thanavaro et al. (2014) conducted a cohort in Heart failure requiring total artificial heart implantation (n=66). Alternative (ALT) indications for TAH implantation vs. Biventricular heart failure (BiVHF) indications for TAH implantation was evaluated on Survival to transplantation (HR 0.42, 95% CI 0.1, 1.7, p=0.2). Total artificial heart implantation for alternative indications showed a trend toward decreased survival to transplantation compared with biventricular heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: